| Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells O De Henau, M Rausch, D Winkler, LF Campesato, C Liu, DH Cymerman, ... Nature 539 (7629), 443, 2016 | 760 | 2016 |
| Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation RR Jenq, C Ubeda, Y Taur, CC Menezes, R Khanin, JA Dudakov, C Liu, ... Journal of Experimental Medicine 209 (5), 903-911, 2012 | 677 | 2012 |
| Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease AM Hanash, JA Dudakov, G Hua, MH O’Connor, LF Young, NV Singer, ... Immunity 37 (2), 339-350, 2012 | 642 | 2012 |
| Interleukin-22 Drives Endogenous Thymic Regeneration in Mice. JA Dudakov, AM Hanash, RR Jenq, LF Young, A Ghosh, NV Singer, ... Science (New York, NY), 2012 | 436 | 2012 |
| CTLA-4 blockade drives loss of T reg stability in glycolysis-low tumours R Zappasodi, I Serganova, IJ Cohen, M Maeda, M Shindo, ... Nature 591 (7851), 652-658, 2021 | 226 | 2021 |
| Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity. A Ghosh, M Smith, SE James, ML Davila, E Velardi, KV Argyropoulos, ... Nature medicine 23 (2), 242-249, 2017 | 220 | 2017 |
| Nrf2 regulates haematopoietic stem cell function JJ Tsai, JA Dudakov, K Takahashi, JH Shieh, E Velardi, AM Holland, ... Nature Cell Biology, 2013 | 214 | 2013 |
| Pharmacologic modulation of RNA splicing enhances anti-tumor immunity SX Lu, E De Neef, JD Thomas, E Sabio, B Rousseau, M Gigoux, DA Knorr, ... Cell 184 (15), 4032-4047. e31, 2021 | 151 | 2021 |
| NOD2 regulates hematopoietic cell function during graft-versus-host disease O Penack, OM Smith, A Cunningham-Bussel, X Liu, U Rao, N Yim, IK Na, ... Journal of Experimental Medicine 206 (10), 2101-2110, 2009 | 114 | 2009 |
| The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease IK Na, SX Lu, NL Yim, GL Goldberg, J Tsai, U Rao, OM Smith, CG King, ... The Journal of clinical investigation 120 (1), 343-356, 2010 | 91 | 2010 |
| Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I … S Mailankody, A Ghosh, M Staehr, TJ Purdon, M Roshal, E Halton, ... Blood 132 (Suppl 1), 959-959, 2018 | 87 | 2018 |
| Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth O Penack, E Henke, D Suh, CG King, OM Smith, IK Na, AM Holland, ... JNCI: Journal of the National Cancer Institute 102 (12), 894-908, 2010 | 73 | 2010 |
| CAR T cell therapy for multiple myeloma: where are we now and where are we headed? A Ghosh, S Mailankody, SA Giralt, CO Landgren, EL Smith, RJ Brentjens Leukemia & lymphoma 59 (9), 2056-2067, 2018 | 69 | 2018 |
| Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo IK Na, JC Markley, JJ Tsai, NL Yim, BJ Beattie, AD Klose, AM Holland, ... Blood 116 (11), e18-e25, 2010 | 54 | 2010 |
| Checkpoint inhibitors in AML: are we there yet? A Ghosh, P Barba, MA Perales British Journal of Haematology 188 (1), 159-167, 2020 | 42 | 2020 |
| Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity A Ghosh, Y Dogan, M Moroz, AM Holland, NL Yim, UK Rao, LF Young, ... The Journal of clinical investigation 123 (6), 2654-2662, 2013 | 29 | 2013 |
| Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series BA Sklar, KA Gervasio, S Leng, A Ghosh, A Chari, AY Wu BMC ophthalmology 19 (1), 1-8, 2019 | 26 | 2019 |
| Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform J Hübner, SS Hoseini, JD Suerth, D Hoffmann, M Maluski, J Herbst, ... Molecular Therapy 24 (7), 1216-1226, 2016 | 24 | 2016 |
| Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras A Ghosh, W Koestner, M Hapke, V Schlaphoff, F Länger, R Baumann, ... Blood 113 (18), 4440-4448, 2009 | 20 | 2009 |
| Chimeric antigen receptor–induced BCL11B suppression propagates NK-like cell development M Maluski, A Ghosh, J Herbst, V Scholl, R Baumann, J Huehn, R Geffers, ... The Journal of clinical investigation 129 (12), 5108-5122, 2019 | 19 | 2019 |
Jennifer J. TsaiMemorial Sloan-Kettering Cancer CenterBestätigte E-Mail-Adresse bei mskcc.org
